PTX prescient therapeutics limited

Ann: PTX-100 receives U.S. FDA Fast Track Designation, page-51

  1. 2,111 Posts.
    lightbulb Created with Sketch. 823
    PTX is way undervalued and with recent announcements and presentations, PTX needs to be re-evaluated by investors, brokers and especially fund managers which should see a major rerating. When you compare peers at a comparable status, it will substantiate this major rerate. PTX seems to be just starting to get this rerate happening. I look forward to seeing how they do this. Miles Prince needs to be a key speaker to brokers and fund managers and this new milestone and his enthusiasm will kick goals. DYOR!!!!
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
4.4¢
Change
-0.002(4.35%)
Mkt cap ! $35.43M
Open High Low Value Volume
4.6¢ 4.6¢ 4.4¢ $30.02K 663.1K

Buyers (Bids)

No. Vol. Price($)
6 691726 4.4¢
 

Sellers (Offers)

Price($) Vol. No.
4.7¢ 632704 2
View Market Depth
Last trade - 16.10pm 25/06/2025 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.